Sunpeaks Ventures to Exhibit Clotamin at the first-ever Thrombosis and Hemostasis Summit of North America
SILVER SPRING, Md., April 16, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS will be an official exhibitor at the Thrombosis and Hemostasis Summit of North America (the "THSNA") to be held May 3-5, 2012 at the Hyatt Regency Chicago.
"Participation as an official exhibitor at this year's THSNA will provide us with the opportunity to showcase the benefits of Clotamin® and interact with over 1,500 clinicians and allied health care professionals on the front line of care for patients with bleeding and/or clotting disorders," stated Mackie A. Barch, CEO of Sunpeaks Ventures. "We look forward to meeting face to face with the many physicians, nurses, pharmacists, and laboratory professionals that are expected to attend the summit from across North America."
The Thrombosis and Hemostasis Summit of North America is a comprehensive scientific meeting dedicated to thrombosis and hemostasis issues. This first-ever joint summit is a collaboration of the leading non-profit organizations in both fields, including the American Thrombosis & Hemostasis Network, the Anticoagulation Forum, the Hemostasis & Thrombosis Research Society, the North American Specialized Coagulation Laboratory Association, the National Blood Clot Alliance, and The Thrombosis Interest Group of Canada.
Clotamin® is the world's first specialized OTC multivitamin product designed exclusively for use by patients on Warfarin® or other anticoagulants (blood thinners).
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-count